IFM Investors Pty Ltd boosted its position in Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 24.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 38,151 shares of the company’s stock after purchasing an additional 7,615 shares during the quarter. IFM Investors Pty Ltd’s holdings in Bath & Body Works were worth $1,824,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in BBWI. Prospera Financial Services Inc bought a new position in Bath & Body Works in the first quarter worth $25,000. Acadian Asset Management LLC bought a new position in shares of Bath & Body Works during the fourth quarter valued at $30,000. CVA Family Office LLC increased its holdings in shares of Bath & Body Works by 153.4% during the first quarter. CVA Family Office LLC now owns 735 shares of the company’s stock valued at $35,000 after acquiring an additional 445 shares in the last quarter. Alpha Paradigm Partners LLC bought a new position in shares of Bath & Body Works during the fourth quarter valued at $40,000. Finally, CWM LLC bought a new position in shares of Bath & Body Works during the fourth quarter valued at $42,000. Institutional investors own 97.11% of the company’s stock.
Bath & Body Works Stock Down 2.8%
BBWI stock opened at $37.36 on Friday. Bath & Body Works, Inc. has a twelve month low of $25.75 and a twelve month high of $82.00. The stock has a market cap of $8.55 billion, a P/E ratio of 8.14, a PEG ratio of 3.63 and a beta of 1.82. The business’s 50-day moving average price is $32.65 and its 200-day moving average price is $44.53.
Bath & Body Works (NYSE:BBWI – Get Rating) last posted its quarterly earnings data on Wednesday, May 18th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.13. Bath & Body Works had a negative return on equity of 69.03% and a net margin of 15.41%. The firm had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.43 billion. On average, equities research analysts expect that Bath & Body Works, Inc will post 2.64 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 17th. Stockholders of record on Friday, June 3rd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, June 2nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.14%. Bath & Body Works’s payout ratio is currently 17.43%.
Insider Activity
In other Bath & Body Works news, insider Thomas E. Mazurek sold 16,338 shares of the company’s stock in a transaction that occurred on Friday, May 27th. The stock was sold at an average price of $42.25, for a total value of $690,280.50. Following the completion of the transaction, the insider now directly owns 11,225 shares in the company, valued at approximately $474,256.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.37% of the company’s stock.
Analyst Ratings Changes
BBWI has been the subject of several analyst reports. Morgan Stanley raised their price target on Bath & Body Works from $64.00 to $66.00 and gave the company an “overweight” rating in a report on Thursday, July 21st. Raymond James started coverage on Bath & Body Works Body Works in a report on Tuesday, July 12th. They set a “strong-buy” rating and a $45.00 price target for the company. Cowen reduced their price objective on Bath & Body Works from $82.00 to $60.00 in a report on Friday, May 20th. JPMorgan Chase & Co. downgraded Bath & Body Works from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $63.00 to $30.00 in a report on Wednesday, June 29th. Finally, Piper Sandler reduced their price objective on Bath & Body Works to $44.00 in a report on Friday, July 22nd. Four investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.c om, the stock has an average rating of “Moderate Buy” and an average price target of $49.90.
Bath & Body Works Company Profile
(Get Rating)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Articles
Receive News & Ratings for Bath & Body Works Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.